Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pinedo

Showing results (281-290 of 569) with videos related to

Pageof 57
Sort By:
British Journal of Cancer|October 1, 1996
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneouslyA H Honkoop, K Hoekman, J Wagstaff, et al.
British Journal of Cancer|September 1, 1992
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerH J Haisma, E Boven, M van Muijen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracilG J Peters, C L van der Wilt, C J van Groeningen, et al.
Cancer Chemotherapy and Pharmacology|February 20, 2008
Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivoRobert Mauritz, Godefridus J Peters, Ietje Kathmann, et al.
Cancer Letters|April 1, 1987
Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein bindingH J Broxterman, C M Kuiper, G J Schuurhuis, et al.
International Journal of Oncology|December 7, 2002
Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell linesC J A Van Moorsel, K Smid, D A Voorn, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1990
Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen speciesJ de Jong, P R Schoofs, R C Onderwater, et al.
Cancer Letters|November 1, 1984
Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in ratsF Elferink, W J Van der Vijgh, S E Van der Poort, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel plus carboplatin in the treatment of ovarian cancerW ten Bokkel Huinink, C Veenhof, T Helmerhorst, et al.
British Journal of Cancer|March 1, 1989
Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymesG J Peters, B J Braakhuis, E A de Bruijn, et al.
Pageof 57

Showing results (281-290 of 569) with videos related to

Sort By:
Pageof 57
British Journal of Cancer|October 1, 1996
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneouslyA H Honkoop, K Hoekman, J Wagstaff, et al.
British Journal of Cancer|September 1, 1992
A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerH J Haisma, E Boven, M van Muijen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracilG J Peters, C L van der Wilt, C J van Groeningen, et al.
Cancer Chemotherapy and Pharmacology|February 20, 2008
Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivoRobert Mauritz, Godefridus J Peters, Ietje Kathmann, et al.
Cancer Letters|April 1, 1987
Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein bindingH J Broxterman, C M Kuiper, G J Schuurhuis, et al.
International Journal of Oncology|December 7, 2002
Effect of gemcitabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell linesC J A Van Moorsel, K Smid, D A Voorn, et al.
Research Communications in Chemical Pathology and Pharmacology|June 1, 1990
Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen speciesJ de Jong, P R Schoofs, R C Onderwater, et al.
Cancer Letters|November 1, 1984
Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in ratsF Elferink, W J Van der Vijgh, S E Van der Poort, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel plus carboplatin in the treatment of ovarian cancerW ten Bokkel Huinink, C Veenhof, T Helmerhorst, et al.
British Journal of Cancer|March 1, 1989
Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymesG J Peters, B J Braakhuis, E A de Bruijn, et al.
Pageof 57